Home/Filings/SCHEDULE 13D/A/0001213900-25-080942
SCHEDULE 13D/A//SEC Filing

LakeShore Biopharma Co., Ltd. SCHEDULE 13D/A

Accession 0001213900-25-080942

CIK 0002078050other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 9:02 AM ET

Size

44.0 KB

Accession

0001213900-25-080942

Issuer

Crystal Peak Investment Inc.

CIK 0002078050

Entity typeother
IncorporatedVirgin Islands, British

Related Parties

1
  • filerCIK 0002078050

Filing Metadata

Form type
SCHEDULE 13D/A
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 9:02 AM ET
Size
44.0 KB